Skip to content

Clinical trials

Myoclonic Epilepsies, Progressive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myoclonic Epilepsies, Progressive Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20151
20221
20231
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Unknown status2
Available1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
n-Lorem Foundation3
Autifony Therapeutics Limited1
Azienda Socio Sanitaria Territoriale di Mantova1
Boston Children's Hospital1
National Human Genome Research Institute (NHGRI)1
Parasail, LLC1
UCB Pharma1
UCB Pharma SA1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myoclonic Epilepsies, Progressive11
Unverricht-Lundborg Syndrome4
Myoclonus3
Alzheimer Disease1
Ataxia1
Chorea1
Dementia1
Epilepsy1
Glycogen Storage Disease1
Heredodegenerative Disorders, Nervous System1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.